Product
Supplier
Encyclopedia
Inquiry
Home > News > Cosmetics Industry News > The country's first 'hydrolyzed zinc hyaluronate' was successfully filed

The country's first 'hydrolyzed zinc hyaluronate' was successfully filed

ECHEMI 2022-07-22

Bloomage Bio, an enterprise in the Jinan area of Shandong Pilot Free Trade Zone, successfully registered with the State Food and Drug Administration as a new raw material for "hydrolyzed zinc hyaluronate" (record number: guozhuangyuanbei 20220008) that can be used in various skin cosmetics. At the same time, it is also the first new raw material that Bloomage Bio has completed the filing since the introduction of the "Regulations on the Supervision and Administration of Cosmetics" and the "Regulations on the Registration and Filing of New Cosmetic Raw Materials" in 2021.

07141e36dcbfc1c826e5653a0d9ccffc

Bloomage Bio is a hyaluronic acid full industry chain platform company integrating R&D, production and sales. The technology of microbial fermentation to produce hyaluronic acid is in an advantageous position. Relying on the two technology platforms of microbial fermentation and cross-linking, the company has established a whole industry chain business system of bioactive materials from raw materials to medical end products, functional skin care products, and functional foods, serving the global pharmaceutical, cosmetic, food and other fields manufacturing enterprises, medical institutions and end users. As a well-known biotechnology company and bioactive material company, Bloomage Bio has been actively deploying the development of "hydrolyzed zinc hyaluronate" products. The "hydrolyzed zinc hyaluronate" successfully filed this time is the industry's first approved new "HA+zinc" hyaluronic acid raw material. Personal care products such as saliva, shampoo, etc.

The medical and health care industry is one of the leading industries in the Jinan area. In terms of industry cultivation, the medical and health care industry plan and the development and cultivation plan for Class I innovative drugs have been drafted successively, and institutional innovation has been used to catalyze technological innovation, model innovation and service innovation. In terms of innovation and breakthrough, the pilot project of the medical device import trade model and the development of the smart Chinese pharmacy model have been successively promoted. Build a provincial-level medical and health care linkage innovation zone, and form a new open development pattern of "free trade pilot zone + linkage innovation zone + radiation-driven zone". Formulate and issue the "China (Shandong) Pilot Free Trade Zone Jinan Area Biomedical Industry Integrated Innovation Cultivation Plan", from the promotion of biopharmaceutical integration reform and innovation pilots, building a full-chain new drug research and development support system, exploring the clinical application of stem cell therapy, and expanding the new Internet Medical services, the planning of characteristic industrial parks for free trade, and the creation of characteristic business cards for hyaluronic acid will help the area cultivate an internationally competitive biomedical industry cluster.

Jinan area is the world's largest production base of hyaluronic acid raw materials. The official approval of the new raw materials means that the domestic production and operation of "hydrolyzed zinc hyaluronate" raw materials and cosmetics are compliant, providing a new product development idea for the middle and downstream cosmetics enterprises in the area, and opening the medical and health care industry chain The "Golden Sub-track". In the next step, Jinan area will focus on hyaluronic acid as a subdivision and characteristic field to conduct differentiated and innovative exploration of the whole chain, and promote the construction of the whole medical and health care industry chain with the integrated system innovation of "small incision, deep excavation, and big breakthrough". Taking the R&D and production of hyaluronic acid as the core competitiveness, using "technological development" for raw material R&D and innovation, building an industrial ecosystem of "medical + technology" integrated development, focusing on exploring new paths and new mechanisms for the entire medical and health care industry chain, actively Build a high-quality resource opening and sharing service platform, solidly promote the construction of a joint innovation zone, help the Jinan area become a new highland for medical care and health care, and continue to make "free trade contributions" to the construction of a strong provincial capital of socialist modernization in a new era!

 

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.